Oral Abstract - SPOTLIGHT Administrative - Assessing blood donor risks

Program Chair(s)

• 

  Mary Townsend, MD (she/her/hers)

  Vice President, Corporate Medical Director
  Vitalant
  Scottsdale, Arizona, United States

  Disclosure(s): No financial relationships to disclose

  PDF

Over half a century ago, the blood bank community, lead in the US by AABB and FDA, developed donor screening questions and eligibility criteria to determine if a given donor is at risk of transmitting an infectious disease through his/her donated blood. With the progression of time and with increased sophistication of surveillance to identify “risky” donors, the donor questions and eligibility have been refined to identify at-risk donors while decreasing the propensity to label such at-risk donors with pejorative language and increasing the sensitivity of donor screening processes and procedures. This session will highlight successes in enhanced donor risk assessment.

Presentations:

• 8:30 AM - 10:00 AM  

  Gender-Specific Individual Donor Assessment (IDA) based Deferral Rates as Compared to MSM Based Deferral in a Large US Blood Collection Establishment
  

  Presenting Author: Ruchika Goel, MD, MPH, CABP (she/her/hers) – Vitalant and Johns Hopkins University
• 8:30 AM - 10:00 AM  

  Implementation of Sexual Risk Behaviour Donor Screening
  

  Presenting Author: Mindy Goldman, MD, FRCPC (she/her/hers) – Canadian Blood Services
• 8:30 AM - 10:00 AM  

  Rebuilding Trust: Canadian Blood Services Issues Historic Apology to 2SLGBTQIA+ Communities
  

  Presenting Author: Graham Sher, O.C (he/him/his) – Canadian Blood Services
• 8:30 AM - 10:00 AM  

  The Relationship Between Rurality and Transfusion-Transmissible Infections Among Blood Donors and the Influence of Demographic Characteristics
  

  Presenting Author: Galen Conti, MPH – American Red Cross